Mode
Text Size
Log in / Sign up

Intravesical prostatic protrusion shows 2.67 odds of bladder outlet obstruction with higher measurement valuesNew data shows how prostate protrusion helps identify bladder issues

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that IPP may serve as an adjunct to clinical findings but cannot replace urodynamic evaluation for BOO diagnosis.

This meta-analysis evaluates the diagnostic accuracy of intravesical prostatic protrusion (IPP) as a marker for bladder outlet obstruction (BOO) in adult men with BPH and LUTS. The analysis included 1253 patients to determine if IPP measurements correlate with urodynamically confirmed BOO.

The primary finding is that greater IPP values are associated with increased odds of urodynamically confirmed BOO, with an odds ratio of 2.67 (95% CI, 1.48-4.79). The sensitivity for detecting BOO using an IPP threshold of approximately 10-12 mm was 71.0%, and the specificity was 75.5%. The area under the summary receiver operating characteristic curve (AUC) was 0.795.

Several limitations affect the certainty of these findings, including the observational nature of the data, relatively small sample sizes in some studies, and significant methodological heterogeneity. There is also an unclear risk of bias across several included studies. Clinically, IPP may serve as a useful adjunct to other clinical findings, but it should not replace urodynamic evaluation when high diagnostic certainty is required.

How this fits prior evidence

This meta-analysis addresses the diagnostic utility of imaging markers in BPH. It complements previous evidence regarding curcumin supplementation for improving IPSS scores and machine learning models for predicting detrusor underactivity in BPH patients, though it focuses specifically on the anatomical marker of IPP rather than pharmacological or predictive modeling.

Men with an enlarged prostate often struggle with symptoms like frequent urination or a weak stream. One specific issue is a blockage at the bladder outlet, which makes it harder for urine to flow out. Doctors are looking for better ways to identify these blockages early on.

A large review of data from over 1,200 men found that measuring intravesical prostatic protrusion (IPP) can help. This is the amount of prostate tissue that pushes into the bladder. The study showed that a larger measurement, specifically over 10 mm, was linked to a much higher chance of having a confirmed blockage.

While this measurement is a helpful extra tool for doctors, it is not perfect. Because the data comes from various studies with different methods and smaller sample sizes, it should not replace standard tests when a doctor needs to be certain about a diagnosis. It serves as a useful piece of the puzzle rather than a standalone test.

What this means for you:
Measuring prostate protrusion into the bladder can help doctors identify potential blockages in men with enlarged prostates.

Common questions

What is intravesical prostatic protrusion (IPP)?

IPP describes the amount of prostate tissue that protrudes into the bladder. In this study, researchers looked at how measuring this distance helps identify a bladder outlet obstruction, which is a physical blockage that makes it harder for men to urinate.

How accurate is this measurement for finding blockages?

The measurement had a sensitivity of 71.0% and a specificity of 75.5% for detecting blockages when the threshold was set between 10 and 12 mm. While it shows a strong link to blockages, it is best used alongside other clinical findings.

Can this test replace standard urodynamic tests?

No, this measurement should not replace urodynamic evaluations when a doctor needs certain results. Because of the study's design and small sample sizes, it is currently viewed as a helpful extra tool rather than a replacement for standard diagnostic procedures.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
PURPOSE: To evaluate the diagnostic accuracy of intravesical prostatic protrusion (IPP) for detecting bladder outlet obstruction (BOO) in men with lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), using urodynamic studies as the reference standard. MATERIALS AND METHODS: A systematic review and meta-analysis was performed in accordance with PRISMA-DTA guidance. Studies were included if they evaluated IPP in adult men with LUTS attributed to BPH and defined BOO using urodynamic criteria, specifically BOO index > 40. Data were extracted to construct 2 × 2 diagnostic tables. Pooled sensitivity and specificity were estimated using a bivariate random-effects model, and overall diagnostic performance was assessed using a summary receiver operating characteristic curve. A random-effects model was also used to estimate the association between IPP > 10 mm and BOO. RESULTS: Ten studies including 1253 men met inclusion criteria. Greater IPP was associated with increased odds of urodynamically confirmed BOO, with a pooled odds ratio of 2.67 (95% CI, 1.48-4.79; I² = 94.6%). The 95% prediction interval ranged from 0.32 to 22.49, indicating substantial between-study variability and uncertainty regarding the association in future populations. Diagnostic meta-analysis across study-defined IPP thresholds of approximately 10-12 mm demonstrated a pooled sensitivity of 71.0% and specificity of 75.5% for detecting BOO. The area under the summary receiver operating characteristic curve was 0.795, consistent with moderate overall diagnostic accuracy. CONCLUSIONS: Available evidence suggests that IPP is associated with urodynamically confirmed BOO and that a threshold of approximately 10 mm may provide moderate diagnostic accuracy. However, the certainty of these findings is limited by the observational design, relatively small sample sizes, methodological heterogeneity, and unclear risk of bias in several included studies. IPP may therefore be useful as an adjunct to other clinical findings but should not replace urodynamic evaluation when diagnostic certainty is required.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.